TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer

Conclusions: TBC1D8 drives OVCA tumorigenesis and metabolic reprogramming, and TBC1D8 serves as an independent prognosis factor for OVCA patients.

Source: Theranostics - June 13, 2019 Category: Molecular Biology Authors: Min Chen, Xiu-Jie Sheng, Yuan-Yi Qin, Song Zhu, Qing-Xia Wu, Liqing Jia, Nan Meng, Yu-Tian He, Guang-Rong Yan Tags: Research Paper Source Type: research